Research and Innovation Action · Running
2D-BioPAD Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease
- Coordinator
- Univerzita Palackeho V Olomouci, Czechia
- Runs
- 1 October 2023 to 30 September 2027
- Status
- Running
- EU funding
- €6.0m
- Total cost
- €6.0m
- Partners
- 11 organisations in 8 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101120706
What the project is doing
In the project's own words, from its summary on CORDIS.
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Univerzita Palackeho V Olomouci | Olomouc | Czechia | Coordinator |
| Zentralinstitut Fuer Seelische Gesundheit | Mannheim | Germany | Participant |
| Evnia Aps | Aarhus C | Denmark | Participant |
| Aristotelio Panepistimio Thessalonikis | Thessaloniki | Greece | Participant |
| Elliniki Etairia Nosoy Alzheimer Kai Syggenon Diatarachon Somateio | Thessaloniki | Greece | Participant |
| Q-Plan International Advisors Pc | Kalamaria, Thessaloniki | Greece | Participant |
| Fundacio Institut Catala De Nanociencia I Nanotecnologia | Bellaterra (Barcelona) | Spain | Participant |
| Ita-Suomen Yliopisto | Kuopio | Finland | Participant |
| Grapheal | La Tronche | France | Participant |
| Novaptech | Gradignan | France | Participant |
| University College Dublin, National University of Ireland, Dublin | Dublin | Ireland | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI